Cargando…
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources
SIMPLE SUMMARY: Using Italian national data from more than 8000 patients, we proposed a novel model calculating the net benefit of liver transplantation (individual benefit minus harm to others on the waiting list) in T2 hepatocellular carcinoma (HCC) patients in different scenarios of transplant ac...
Autores principales: | Cillo, Umberto, Vitale, Alessandro, Volk, Michael L., Frigo, Anna Chiara, Feltracco, Paolo, Cattelan, Annamaria, Brancaccio, Giuseppina, Feltrin, Giuseppe, Angeli, Paolo, Burra, Patrizia, Lonardi, Sara, Trapani, Silvia, Cardillo, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003429/ https://www.ncbi.nlm.nih.gov/pubmed/33808790 http://dx.doi.org/10.3390/cancers13061416 |
Ejemplares similares
-
Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs
por: Cillo, U., et al.
Publicado: (2021) -
Invasive fungal infection before and after liver transplantation
por: Ferrarese, Alberto, et al.
Publicado: (2020) -
Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis
por: Incicco, Simone, et al.
Publicado: (2023) -
Colon Rectal Liver Metastases: The Role of the Liver Transplantation in the Era of the Transplant Oncology and Precision Medicine
por: Finotti, Michele, et al.
Publicado: (2021) -
Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)